MIST ▲ +9.1% - Milestone Pharmaceuticals Inc.
$MIST - Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
13-NOV-2026 07:08 AM ET
Share this post
More filings for $MIST
MIST ▲ +2.7% - Milestone Pharmaceuticals Inc.Nov 3, 2026MIST ▲ +7.0% - Milestone Pharmaceuticals Inc.Oct 9, 2026MIST ▲ +2.3% - Milestone Pharmaceuticals Inc.Sep 24, 2026MIST ▲ +5.9% - Milestone Pharmaceuticals Inc.Sep 3, 2026MIST ▼ -0.9% - Milestone Pharmaceuticals Inc.Sep 2, 2026
View full $MIST filing history →💬 Comments
Loading comments…
Leave a comment